These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17569876)

  • 1. Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial.
    Lyden PD; Shuaib A; Lees KR; Davalos A; Davis SM; Diener HC; Grotta JC; Ashwood TJ; Hardemark HG; Svensson HH; Rodichok L; Wasiewski WW; Ahlberg G;
    Stroke; 2007 Aug; 38(8):2262-9. PubMed ID: 17569876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials.
    Diener HC; Lees KR; Lyden P; Grotta J; Davalos A; Davis SM; Shuaib A; Ashwood T; Wasiewski W; Alderfer V; Hårdemark HG; Rodichok L;
    Stroke; 2008 Jun; 39(6):1751-8. PubMed ID: 18369171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NXY-059 for the treatment of acute ischemic stroke.
    Shuaib A; Lees KR; Lyden P; Grotta J; Davalos A; Davis SM; Diener HC; Ashwood T; Wasiewski WW; Emeribe U;
    N Engl J Med; 2007 Aug; 357(6):562-71. PubMed ID: 17687131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NXY-059 for acute ischemic stroke.
    Lees KR; Zivin JA; Ashwood T; Davalos A; Davis SM; Diener HC; Grotta J; Lyden P; Shuaib A; Hårdemark HG; Wasiewski WW;
    N Engl J Med; 2006 Feb; 354(6):588-600. PubMed ID: 16467546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerability and pharmacokinetics of the nitrone NXY-059 in patients with acute stroke.
    Lees KR; Sharma AK; Barer D; Ford GA; Kostulas V; Cheng YF; Odergren T
    Stroke; 2001 Mar; 32(3):675-80. PubMed ID: 11239186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additional outcomes and subgroup analyses of NXY-059 for acute ischemic stroke in the SAINT I trial.
    Lees KR; Davalos A; Davis SM; Diener HC; Grotta J; Lyden P; Shuaib A; Ashwood T; Hardemark HG; Wasiewski W; Emeribe U; Zivin JA;
    Stroke; 2006 Dec; 37(12):2970-8. PubMed ID: 17068304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase 1, placebo-controlled, randomised, double-blind (within dose panels) study evaluating the safety, tolerability and pharmacokinetics of intravenous NXY-059 in Japanese subjects.
    Watabe M; Cheng YF; Nilsson D; Itoh Y; Kumagai Y
    Curr Med Res Opin; 2007 Aug; 23(8):1849-57. PubMed ID: 17605894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerability of NXY-059 at higher target concentrations in patients with acute stroke.
    Lees KR; Barer D; Ford GA; Hacke W; Kostulas V; Sharma AK; Odergren T;
    Stroke; 2003 Feb; 34(2):482-7. PubMed ID: 12574564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of 8-hour intravenous infusion of NXY-059: a phase I, randomized, double-blind (within dose panels), placebo-controlled study in healthy Chinese volunteers.
    Cheng YF; Jiang J; Hu P; Reinholdsson I; Guo W; Asenblad N; Nilsson D
    Clin Ther; 2008 Dec; 30(12):2342-53. PubMed ID: 19167593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, tolerability and pharmacokinetics of escalating doses of NXY-059 in healthy young and elderly subjects.
    Wemer J; Cheng YF; Nilsson D; Reinholdsson I; Fransson B; Lanbeck Vallén K; Nyman L; Eriksson C; Björck S; Schulman S
    Curr Med Res Opin; 2006 Sep; 22(9):1813-23. PubMed ID: 16968585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reassessment of defibrase in treatment of acute cerebral infarction: a multicenter, randomized, double-blind, placebo-controlled trial.
    Cooperative Group for Reassessment of Defibrase
    Chin Med Sci J; 2005 Sep; 20(3):151-8. PubMed ID: 16261883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NXY-059 does not affect bleeding time in healthy volunteers: a randomized, double-blind, placebo-controlled, 3-period crossover phase I study.
    Nilsson D; Wemer J; Cheng YF; Reinholdsson I; Englund G; Egberg N; Schulman S
    J Clin Pharmacol; 2007 Feb; 47(2):264-72. PubMed ID: 17244778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NXY-059: review of neuroprotective potential for acute stroke.
    Fong JJ; Rhoney DH
    Ann Pharmacother; 2006 Mar; 40(3):461-71. PubMed ID: 16507608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of disodium 4-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (NXY-059), a free radical trapping agent, in a rat model of hemorrhagic stroke.
    Peeling J; Del Bigio MR; Corbett D; Green AR; Jackson DM
    Neuropharmacology; 2001 Mar; 40(3):433-9. PubMed ID: 11166336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The spot sign and tranexamic acid on preventing ICH growth--AUStralasia Trial (STOP-AUST): protocol of a phase II randomized, placebo-controlled, double-blind, multicenter trial.
    Meretoja A; Churilov L; Campbell BC; Aviv RI; Yassi N; Barras C; Mitchell P; Yan B; Nandurkar H; Bladin C; Wijeratne T; Spratt NJ; Jannes J; Sturm J; Rupasinghe J; Zavala J; Lee A; Kleinig T; Markus R; Delcourt C; Mahant N; Parsons MW; Levi C; Anderson CS; Donnan GA; Davis SM
    Int J Stroke; 2014 Jun; 9(4):519-24. PubMed ID: 23981692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1).
    Lampl Y; Zivin JA; Fisher M; Lew R; Welin L; Dahlof B; Borenstein P; Andersson B; Perez J; Caparo C; Ilic S; Oron U
    Stroke; 2007 Jun; 38(6):1843-9. PubMed ID: 17463313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DP-b99, a membrane-activated metal ion chelator, as neuroprotective therapy in ischemic stroke.
    Diener HC; Schneider D; Lampl Y; Bornstein NM; Kozak A; Rosenberg G
    Stroke; 2008 Jun; 39(6):1774-8. PubMed ID: 18403736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage.
    Mayer SA; Brun NC; Broderick J; Davis S; Diringer MN; Skolnick BE; Steiner T;
    Stroke; 2005 Jan; 36(1):74-9. PubMed ID: 15569871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NXY-059 does not significantly interact with furosemide in healthy volunteers.
    Strid S; Nilsson D; Borgå O; Wemer J; Grahnén A
    J Clin Pharmacol; 2006 Dec; 46(12):1417-25. PubMed ID: 17101741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.